1. Growth hormone excess and the development of growth hormone receptor antagonists;Higham;Experimental Physiology,2008
2. The place of pegvisomant in the management of acromegaly;Parkinson;Expert Opinion on Investigational Drugs,2001
3. Medical therapy of acromegaly;Plöckinger;International Journal of Endocrinology,2012
4. Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-1 but does not acutely stimulate serum GH;Thorner;The Journal of Clinical Endocrinology and Metabolism,1999
5. The future of growth hormone antagonists;Van der Lely;Current Opinion in Pharmacology,2002